國家衛生研究院 NHRI:Item 3990099045/12122

NHRI > National Institute of Infectious Diseases and Vaccinology > Yung-Chih Hu > Periodical Articles > Item 3990099045/12122

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/12122

Title:	Evaluation of novel disposable bioreactors on pandemic influenza virus production
Authors:	Lai, CC;Weng, TC;Tseng, YF;Chiang, JR;Lee, MS;Hu, AYC
Contributors:	National Institute of Infectious Diseases and Vaccinology
Abstract:	Since 1997, the highly pathogenic influenza H5N1 virus has spread from Hong Kong. According to the WHO bulletin report, the H5N1 virus is a zoonotic disease threat that has infected more than 850 humans, causing over 450 deaths. In addition, an outbreak of another new and highly pathogenic influenza virus (H7N9) occurred in 2013 in China. These highly pathogenic influenza viruses could potentially cause a worldwide pandemic. it is crucial to develop a rapid production platform to meet this surge demand against any possible influenza pandemic. A potential solution for this problem is the use of cell-based bioreactors for rapid vaccine production. These novel bioreactors, used for cell-based vaccine production, possess various advantages. For example, they enable a short production time, allow for the handling highly pathogenic influenza in closed environments, and can be easily scaled up. In this study, two novel disposable cell-based bioreactors, BelloCell and TideCell, were used to produce H5N1 clade II and H7N9 candidate vaccine viruses (CVVs). Madin- Darby canine kidney (MDCK) cells were used for the production of these influenza CVVs. A novel bench-scale bioreactor named BelloCell bioreactor was used in the study. All culturing conditions were tested and scaled to 10 L industrial-scale bioreactor known as TideCell002. The performances of between BelloCell and TideCell were similar in cell growth, the average MDCK cell doubling time was slightly decreased to 25 hours. The systems yielded approximately 39.2 and 18.0 μg/ml of HA protein with the 10-liter TideCell002 from the H5N1 clade II and H7N9 CVVs, respectively. The results of this study not only highlight the overall effectiveness of these bioreactors but also illustrate the potential of maintaining the same outcome when scaled up to industrial production, which has many implications for faster vaccine production. Although additional studies are required for process optimization, the results of this study are promising and show that oscillating bioreactors may be a suitable platform for pandemic influenza virus production.
Date:	2019-08-12
Relation:	PLoS ONE. 2019 Aug 12;14(8):Article number 0220803.
Link to:	http://dx.doi.org/10.1371/journal.pone.0220803
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1932-6203&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000485006800033
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85070662422
Appears in Collections:	[Yung-Chih Hu] Periodical Articles [Min-Shi Lee] Periodical Articles

Files in This Item:

File	Description	Size	Format
SCP85070662422.pdf		1004Kb	Adobe PDF	326	View/Open

Loading...